Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-08-19 | Milligan Sandra | Director | Buy | 26,050 | $1.92 | $50,016.00 | +81.4% | → |
| 2024-06-24 | Aranda Richard | Chief Medical Officer | Sell | 1,908 | $0.66 | $1,260.23 | -1.0% | → |
| 2024-06-21 | Hasnain Faheem | President & CEO | Buy | 372,000 | $0.67 | $250,281.60 | +7.4% | → |
| 2024-06-18 | Giraudo Bryan | COO/CFO | Buy | 100,000 | $0.59 | $59,110.00 | +26.3% | → |
| 2024-06-17 | Smith Robert Paul JR | Chief Commercial Officer | Buy | 25,000 | $0.60 | $15,050.00 | New | → |
| 2024-03-27 | Christian Waage | EVP, Tech Ops and Admin | Sell | 6,430 | $1.16 | $7,429.87 | -1.1% | → |
| 2024-03-27 | Giraudo Bryan | COO/CFO | Sell | 6,430 | $1.16 | $7,430.51 | -6.5% | → |
| 2024-03-27 | Hasnain Faheem | President & CEO | Sell | 23,172 | $1.16 | $26,772.93 | -16.2% | → |
| 2024-03-18 | Aranda Richard | Chief Medical Officer | Sell | 4,018 | $1.33 | $5,341.93 | -2.0% | → |
| 2024-03-18 | Peterson Caryn | EVP, Regulatory Affairs | Sell | 4,018 | $1.33 | $5,342.73 | -7.5% | → |
| 2023-11-15 | Milligan Sandra | Director | Buy | 32,000 | $0.79 | $25,212.80 | New | → |
| 2023-11-13 | Giraudo Bryan | COO/CFO | Buy | 200,000 | $0.56 | $112,880.00 | +111.1% | → |
| 2023-06-22 | Aranda Richard | Chief Medical Officer | Sell | 1,814 | $1.29 | $2,340.06 | -0.9% | → |
| 2023-04-04 | Giraudo Bryan | COO/CFO | Buy | 55,000 | $1.02 | $56,094.50 | +77.5% | → |
| 2023-03-22 | Hasnain Faheem | President & CEO | Buy | 878,572 | $1.14 | $1,000,389.23 | +7.7% | → |
| 2023-03-20 | Christian Waage | EVP, Tech Ops and Admin | Buy | 18,500 | $1.20 | $22,144.50 | +133.2% | → |
| 2023-03-20 | Giraudo Bryan | COO/CFO | Buy | 50,000 | $0.97 | $48,435.00 | +238.2% | → |
| 2023-03-16 | Carter Laura | Chief Scientific Officer | Sell | 6,029 | $1.10 | $6,619.84 | -7.3% | → |
| 2023-03-16 | Aranda Richard | Chief Medical Officer | Sell | 7,563 | $1.10 | $8,304.17 | -3.7% | → |
| 2023-03-16 | Peterson Caryn | EVP, Regulatory Affairs | Sell | 7,564 | $1.10 | $8,305.27 | -12.3% | → |
| 2022-10-24 | Peterson Caryn | EVP, Regulatory Affairs | Sell | 4,757 | $12.07 | $57,431.26 | -7.2% | → |
| 2022-10-24 | Carter Laura | Chief Scientific Officer | Sell | 4,876 | $12.07 | $58,867.95 | -5.6% | → |
| 2022-10-24 | Aranda Richard | Chief Medical Officer | Sell | 4,757 | $12.07 | $57,431.26 | -2.3% | → |
| 2022-07-15 | Carter Laura | Chief Scientific Officer | Buy | 6,934 | $7.21 | $49,994.14 | +8.6% | → |
| 2022-07-15 | Christian Waage | EVP, Tech Ops and Admin | Buy | 6,934 | $7.21 | $49,994.14 | +99.7% | → |
| 2022-07-15 | Giraudo Bryan | COO/CFO | Buy | 13,869 | $7.21 | $99,995.49 | +194.8% | → |
| 2022-07-15 | Hasnain Faheem | President & CEO | Buy | 138,696 | $7.21 | $999,998.16 | +4.0% | → |
| 2022-07-01 | Carter Laura | Chief Scientific Officer | Sell | 8,808 | $8.25 | $72,648.38 | -9.9% | → |
| 2022-06-22 | Aranda Richard | Chief Medical Officer | Sell | 1,778 | $6.88 | $12,232.64 | -0.8% | → |
| 2022-05-04 | Carter Laura | Chief Scientific Officer | Sell | 1,262 | $7.20 | $9,086.40 | -1.4% | → |
| 2022-03-23 | Hasnain Faheem | President & CEO | Sell | 19,035 | $8.92 | $169,697.03 | -11.7% | → |
| 2022-03-23 | Christian Waage | EVP, Tech Ops and Admin | Sell | 10,722 | $8.92 | $95,586.63 | -1.8% | → |
| 2022-03-23 | Giraudo Bryan | COO/CFO | Sell | 10,722 | $8.92 | $95,586.63 | -9.8% | → |
| 2022-03-16 | Carter Laura | Chief Scientific Officer | Sell | 5,002 | $8.28 | $41,406.56 | -5.2% | → |
| 2022-03-16 | Peterson Caryn | EVP, Regulatory Affairs | Sell | 6,279 | $8.28 | $51,977.56 | -8.7% | → |
| 2022-03-16 | Aranda Richard | Chief Medical Officer | Sell | 6,278 | $8.28 | $51,975.56 | -2.9% | → |
| 2021-10-25 | Peterson Caryn | EVP, Regulatory Affairs | Sell | 2,377 | $12.25 | $29,118.25 | -3.2% | → |
| 2021-10-25 | Carter Laura | Chief Scientific Officer | Sell | 2,377 | $12.25 | $29,118.25 | -2.4% | → |
| 2021-10-25 | Aranda Richard | Chief Medical Officer | Sell | 2,377 | $12.25 | $29,118.25 | -1.1% | → |
| 2021-03-23 | Salter-Cid Luisa | Chief Scientific Officer | Sell | 5,491 | $9.48 | $52,051.93 | -2.6% | → |
| 2021-03-23 | Giraudo Bryan | Chief Financial Officer | Sell | 5,490 | $9.48 | $52,045.75 | -4.8% | → |
| 2021-03-23 | Christian Waage | EVP & General Counsel | Sell | 5,490 | $9.48 | $52,050.69 | -0.9% | → |
| 2020-10-14 | Hasnain Faheem | Director | Buy | 96,520 | $10.36 | $999,995.46 | +2.9% | → |
| 2020-10-14 | Christian Waage | EVP & General Counsel | Buy | 2,500 | $9.53 | $23,818.00 | +56.1% | → |
| 2020-10-14 | Giraudo Bryan | Chief Financial Officer | Buy | 3,000 | $10.01 | $30,036.00 | +72.8% | → |
| 2020-06-23 | Giraudo Bryan | Chief Financial Officer | Buy | 2,000 | $12.96 | $25,922.40 | +94.3% | → |
| 2019-12-30 | Dupont Jakob | Chief Medical Officer | Sale+OE | 41,994 | $15.04 | $631,538.11 | -100% | → |